Auflistung nach Autor:in "Schenk, Andrea"
1 - 2 von 2
Treffer pro Seite
Sortieroptionen
- WorkshopbeitragApplication Scenarios for 3D-Printed Organ Models for Collaboration in VR & AR(Mensch und Computer 2019 - Workshopband, 2019) Muender, Thomas; Reinschluessel, Anke; Zargham, Nima; Döring, Tanja; Wenig, Dirk; Malaka, Rainer; Fischer, Roland; Zachmann, Gabriel; Schumann, Christian; Kraft, Valentin; Schenk, Andrea; Uslar, Verena; Weyhe, Dirk; Nopper, Hans; Lück, ThomasMedical software for computer-assisted surgery often solely supports one phase of the surgical process, e.g., surgery planning. This paper describes a concept for a system, which can be seamlessly used in the preoperative planning phase, in the intraoperative phase for viewing the planning data, as well as for training and education. A combination of virtual and augmented reality with a multi-user functionality will support the three phases. 3D-printed organ models will be used as interaction devices for more intuitive interaction with the visual data and for educating future surgeons. We present the three application scenarios for this concept in detail and discuss the research opportunities.
- KonferenzbeitragSoftware-supported planning of liver interventions – experience of more than10 years(INFORMATIK 2006 – Informatik für Menschen, Band 1, 2006) Schenk, Andrea; Bourquain, Holger; Zidowitz, Stephan; Hindennach, Milo; Konrad, Olaf; Peitgen, Heinz-OttoComputer assistance for the planning of liver interventions was the main focus of the initial project at our institution. Starting with the idea to compute patient-individual liver territories for tumor resections, dedicated algorithms were developed and integrated into a first prototypical software-assistant. Over one decade, experiences together with several clinical partners led to a software-tool that has proven clinical relevance. Until now, more than 1600 liver interventions like tumor resections, ablations, and living donor liver transplantations were planned with the help of the software, which was FDA-approved in 2005. While the planning itself is offered worl-wide as a commercial service, the software is being extended continuously and builds the basis for subsequent ne applications and studies in different research projects.